Retinoic acid for autism with 15q11-13 duplication
Treatments studied
Part of Mental health clinical trials.
This study tests a medicine (all-trans retinoic acid) for children with autism who also have a specific genetic change (15q11-13 duplication). The goal is to see if it can help with autism symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a formal autism diagnosis (using DSM-5) from doctors.
- A genetic test must show a specific chromosome change (15q11-13 duplication) that involves the UBE3A gene.
- No infections (like colds or ongoing infections) in the past 3 months.
- No seizures (fits) in the past 6 months.
- No vitamin A or mineral supplements taken in the past month.
- No chronic health issues like liver, kidney, or thyroid problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a structured remote (video/at-home) therapy plan for toddlers who have been screened as having autism. It may help improve toddler development and support families with regular follow-up.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
This study tests whether folinic acid (a type of B vitamin) can help improve symptoms of autism in children. Researchers want to see if this supplement, combined with your child's current treatments, might make a difference.
This study tests whether folinic acid (a B-vitamin supplement) can help improve autism symptoms in children ages 3–6. Folinic acid may support brain function, and researchers want to see if it works better than placebo (a dummy pill).
This trial tests an investigational medication for children and teenagers with dup15q syndrome, a genetic condition that can cause developmental delays and other challenges. The study aims to see if the drug is safe and helpful.
Hear when a new Dup15q Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.